Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ALAB vs GSK✓SelectedUSD · GSKALAB vs GSK performance historyLatest closeAs of-14.77%11/20
Stock and ETF performance explorer

ALAB vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+29.5%
GSK return
+6.1%
Excess return
+23.3%
Maximum drawdown
-62.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-14.8%-0.1%-14.6%-14.8%
7D-18.7%-5.3%-13.4%-21.1%
30D-37.8%-3.7%-34.2%-38.8%
3M-37.9%-7.3%-30.7%-39.6%
6M-37.3%-4.2%-33.0%-37.4%
YTD+8.4%+0.9%+7.5%+18.1%
1Y+29.5%+7.3%+22.2%+44.3%
All+29.5%+6.1%+23.3%+44.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling